Cipla - Quaterly Results

13 May 2025 Evaluate
The revenue zoomed 18.86% to Rs. 47978.90 millions for the quarter ended March 2025 as compared to Rs. 40366.60 millions during the corresponding quarter last year.Net profit surges 51.26% to Rs. 14854.00  millions  from Rs. 9820.30 millions in the quarter ended March 2025.Operating profit for the quarter ended March 2025 rose to 16120.80 millions as compared to 13665.00 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 47978.90 40366.60 18.86 190448.50 165743.40 14.91 190448.50 165743.40 14.91
Other Income 2933.70 5386.10 -45.53 9847.20 10706.60 -8.03 9847.20 10706.60 -8.03
PBIDT 16120.80 13665.00 17.97 67631.60 55548.10 21.75 67631.60 55548.10 21.75
Interest 34.90 54.50 -35.96 151.10 202.50 -25.38 151.10 202.50 -25.38
PBDT 19032.50 13610.50 39.84 70427.10 55345.60 27.25 70427.10 55345.60 27.25
Depreciation 1477.00 1368.10 7.96 5738.90 5875.90 -2.33 5738.90 5875.90 -2.33
PBT 17555.50 12242.40 43.40 64688.20 49469.70 30.76 64688.20 49469.70 30.76
TAX 2701.50 2422.10 11.54 13111.70 12327.80 6.36 13111.70 12327.80 6.36
Deferred Tax -625.60 20.30 -3181.77 -491.50 60.90 -907.06 -491.50 60.90 -907.06
PAT 14854.00 9820.30 51.26 51576.50 37141.90 38.86 51576.50 37141.90 38.86
Equity 1615.20 1614.70 0.03 1615.20 1614.70 0.03 1615.20 1614.70 0.03
PBIDTM(%) 33.60 33.85 -0.75 35.51 33.51 5.96 35.51 33.51 5.96

Cipla Share Price

1520.00 -1.20 (-0.08%)
05-Dec-2025 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.50
Dr. Reddys Lab 1274.50
Cipla 1520.00
Zydus Lifesciences 930.75
Lupin 2098.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×